BioGend Therapeutics Co., Ltd. (code:6733) is scheduled for listing on TPEx on January 28, 2021. TPEx will host a listing ceremony on 11F IR Center of the TPEx office building. BioGend’s management teams as well as their underwriters and accounting firms will be invited to join the ceremony and celebrate the company’s successful listing on TPEx.
|